title: [Pro-survival signaling pathways activated by BCR-ABL oncogene in chronic myelogenous leukemia cells: the role of the perk-EIF2α signal path and acetylation of p53].
authors: Monika
authors: M
authors: Kusio-Kobiałka
mesh_terms: D001549:Benzamides / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism*; D016044:Fusion Proteins, bcr-abl / Q000378:metabolism*; D049674:History, 21st Century; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism*; D010766:Phosphorylation; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology*; D014178:Translocation, Genetic / Q000235:genetics; D014407:Tumor Cells, Cultured; D019892:eIF-2 Kinase / Q000378:metabolism*
chemical_list: D001549:Benzamides; D015852:Eukaryotic Initiation Factor-2; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; C460640:EIF2AK3 protein, human; D019892:eIF-2 Kinase